TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
BME

BlackRock Health Sciences Trust

Financial Services · Asset Management

43.30$ -0.6% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet BME
Line item 2006 2007 2008 2010 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– +9.7% -20.7% – – +20.5% +11.9% -1.8% -9.1% +22.3% +6.2% +386.5% -67.9% +17.0% -6.6% -1.7% +29.9% -26.4%
– – – – – -64.5% -83.5% +493.0% -15.3% -83.9% +177.8% +28.4% -61.9% -99.8% +224.8% -1,313.6% – -79.9%
– +89.4% – – – +38.2% +81.2% -73.2% +17,132.4% -99.5% -70.0% +173,967.0% -57.8% -99.5% +224.8% -82.9% +13,259.4% -99.2%
– – – – – +38.2% +81.2% +195,564.4% +1.0% +61.2% +80.1% -98.1% -57.8% -99.5% +224.8% -82.9% +4,973,458.2% -81.5%
– -87.9% +2,556.0% – – +3.7% -84.7% +539.6% -24.7% -81.9% +177.8% -31.4% -34.6% +746.0% -25.5% -33.4% -24.2% -64.2%
– – – – – – – -100.0% – – – – -100.0% – -100.0% – – –
– – – – – – – – – – – – – – – – – –
– – – – – – – – – – – – – – – – – –
– – – – – – – – – – – – – – – – – –
– -16.0% +23.4% – – -57.6% -10.2% +0.1% -16.9% -3.3% +2.0% +3,226.6% -90.8% +167.4% -74.2% +34.3% -24.4% -69.6%
– – – – – -57.6% -10.2% +0.1% -16.9% -3.3% -66.3% +63.8% +466.6% +44.9% -98.1% +3,311.3% – –
– – – – – – – – – +3.2% -96.4% +5,328.9% -59.5% +106.0% -98.6% +1,978.3% -65.2% –
– -87.5% +120.0% – – -42.1% -83.5% +196.2% -4.5% -100.0% – +63.8% -92.5% +10,828.5% -98.1% – – -57.0%
– – +95.1% – – – – – – – – – – – – – – –
– +10.6% -22.0% – – +23.7% +12.2% -1.8% -9.0% +22.6% +6.3% +363.9% +84.8% -79.3% -4.1% -2.0% +30.7% -26.1%
– +67.4% -103.1% – – +132.4% +32.1% -100.5% – -305.2% – +17.6% +76.4% +13.8% -25.2% -3.1% -201.8% –
– – – – +1.5% +0.4% +0.9% +5.3% +5.2% +2.8% -2.1% +1,195.6% +0.0% +0.2% -88.8% +10.6% -4.9% -1.9%

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?